Selected research
Industry Growth & Trends
Global Nitroglycerin for Angina Industry Growth and Trends Forecast to 2032
Market perspective
The global Nitroglycerin for Angina market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Nitroglycerin for Angina is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Nitroglycerin for Angina is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nitroglycerin for Angina is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Nitroglycerin for Angina include Sandoz, Mylan, Pfizer, Us Pharma, Sigmapharm Laboratories, Hercon Pharmaceuticals, Glenmark, Espero Pharmaceuticals and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Nitroglycerin for Angina market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Nitroglycerin for Angina market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nitroglycerin for Angina market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nitroglycerin for Angina.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Nitroglycerin for Angina market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Nitroglycerin for Angina Market by Company
Sandoz
Mylan
Pfizer
Us Pharma
Sigmapharm Laboratories
Hercon Pharmaceuticals
Glenmark
Espero Pharmaceuticals
Dr. Reddy's Laboratories
Nitroglycerin for Angina Segment by Type
Transdermal
Tablet
Powder
Nitroglycerin for Angina Segment by Application
Relief
Prophylaxis
Nitroglycerin for Angina Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nitroglycerin for Angina market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nitroglycerin for Angina and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nitroglycerin for Angina.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nitroglycerin for Angina manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Nitroglycerin for Angina in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Transdermal
- Tablet
- Powder
Applications
- Relief
- Prophylaxis
Companies covered
- Sandoz
- Mylan
- Pfizer
- Us Pharma
- Sigmapharm Laboratories
- Hercon Pharmaceuticals
- Glenmark
- Espero Pharmaceuticals
- Dr. Reddy's Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Nitroglycerin for Angina Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Nitroglycerin for Angina Sales Estimates and Forecasts (2021-2032)
- 1.3 Nitroglycerin for Angina Market by Type
- 1.3.1 Transdermal
- 1.3.2 Tablet
- 1.3.3 Powder
- 1.4 Global Nitroglycerin for Angina Market Size by Type
- 1.4.1 Global Nitroglycerin for Angina Market Size Overview by Type (2021-2032)
- 1.4.2 Global Nitroglycerin for Angina Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Nitroglycerin for Angina Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Nitroglycerin for Angina Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Nitroglycerin for Angina Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Nitroglycerin for Angina Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Nitroglycerin for Angina Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Nitroglycerin for Angina Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Nitroglycerin for Angina Industry Trends
- 2.2 Nitroglycerin for Angina Industry Drivers
- 2.3 Nitroglycerin for Angina Industry Opportunities and Challenges
- 2.4 Nitroglycerin for Angina Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Nitroglycerin for Angina Revenue (2021-2026)
- 3.2 Global Top Players by Nitroglycerin for Angina Sales (2021-2026)
- 3.3 Global Top Players by Nitroglycerin for Angina Price (2021-2026)
- 3.4 Global Nitroglycerin for Angina Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Nitroglycerin for Angina Major Company Production Sites & Headquarters
- 3.6 Global Nitroglycerin for Angina Company, Product Type & Application
- 3.7 Global Nitroglycerin for Angina Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Nitroglycerin for Angina Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Nitroglycerin for Angina Players Market Share by Revenue in 2025
- 3.8.3 2025 Nitroglycerin for Angina Tier 1, Tier 2, and Tier 3
4 Nitroglycerin for Angina Regional Status and Outlook
- 4.1 Global Nitroglycerin for Angina Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Nitroglycerin for Angina Historic Market Size by Region
- 4.2.1 Global Nitroglycerin for Angina Sales in Volume by Region (2021-2026)
- 4.2.2 Global Nitroglycerin for Angina Sales in Value by Region (2021-2026)
- 4.2.3 Global Nitroglycerin for Angina Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Nitroglycerin for Angina Forecasted Market Size by Region
- 4.3.1 Global Nitroglycerin for Angina Sales in Volume by Region (2027-2032)
- 4.3.2 Global Nitroglycerin for Angina Sales in Value by Region (2027-2032)
- 4.3.3 Global Nitroglycerin for Angina Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nitroglycerin for Angina by Application
- 5.1 Nitroglycerin for Angina Market by Application
- 5.1.1 Relief
- 5.1.2 Prophylaxis
- 5.2 Global Nitroglycerin for Angina Market Size by Application
- 5.2.1 Global Nitroglycerin for Angina Market Size Overview by Application (2021-2032)
- 5.2.2 Global Nitroglycerin for Angina Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Nitroglycerin for Angina Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Nitroglycerin for Angina Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Nitroglycerin for Angina Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Nitroglycerin for Angina Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Nitroglycerin for Angina Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Nitroglycerin for Angina Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Sandoz
- 6.1.1 Sandoz Company Information
- 6.1.2 Sandoz Business Overview
- 6.1.3 Sandoz Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Sandoz Nitroglycerin for Angina Product Portfolio
- 6.1.5 Sandoz Recent Developments
- 6.2 Mylan
- 6.2.1 Mylan Company Information
- 6.2.2 Mylan Business Overview
- 6.2.3 Mylan Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Mylan Nitroglycerin for Angina Product Portfolio
- 6.2.5 Mylan Recent Developments
- 6.3 Pfizer
- 6.3.1 Pfizer Company Information
- 6.3.2 Pfizer Business Overview
- 6.3.3 Pfizer Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Pfizer Nitroglycerin for Angina Product Portfolio
- 6.3.5 Pfizer Recent Developments
- 6.4 Us Pharma
- 6.4.1 Us Pharma Company Information
- 6.4.2 Us Pharma Business Overview
- 6.4.3 Us Pharma Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Us Pharma Nitroglycerin for Angina Product Portfolio
- 6.4.5 Us Pharma Recent Developments
- 6.5 Sigmapharm Laboratories
- 6.5.1 Sigmapharm Laboratories Company Information
- 6.5.2 Sigmapharm Laboratories Business Overview
- 6.5.3 Sigmapharm Laboratories Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sigmapharm Laboratories Nitroglycerin for Angina Product Portfolio
- 6.5.5 Sigmapharm Laboratories Recent Developments
- 6.6 Hercon Pharmaceuticals
- 6.6.1 Hercon Pharmaceuticals Company Information
- 6.6.2 Hercon Pharmaceuticals Business Overview
- 6.6.3 Hercon Pharmaceuticals Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Hercon Pharmaceuticals Nitroglycerin for Angina Product Portfolio
- 6.6.5 Hercon Pharmaceuticals Recent Developments
- 6.7 Glenmark
- 6.7.1 Glenmark Company Information
- 6.7.2 Glenmark Business Overview
- 6.7.3 Glenmark Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Glenmark Nitroglycerin for Angina Product Portfolio
- 6.7.5 Glenmark Recent Developments
- 6.8 Espero Pharmaceuticals
- 6.8.1 Espero Pharmaceuticals Company Information
- 6.8.2 Espero Pharmaceuticals Business Overview
- 6.8.3 Espero Pharmaceuticals Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Espero Pharmaceuticals Nitroglycerin for Angina Product Portfolio
- 6.8.5 Espero Pharmaceuticals Recent Developments
- 6.9 Dr. Reddy's Laboratories
- 6.9.1 Dr. Reddy's Laboratories Company Information
- 6.9.2 Dr. Reddy's Laboratories Business Overview
- 6.9.3 Dr. Reddy's Laboratories Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Dr. Reddy's Laboratories Nitroglycerin for Angina Product Portfolio
- 6.9.5 Dr. Reddy's Laboratories Recent Developments
7 North America by Country
- 7.1 North America Nitroglycerin for Angina Sales by Country
- 7.1.1 North America Nitroglycerin for Angina Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Nitroglycerin for Angina Sales by Country (2021-2026)
- 7.1.3 North America Nitroglycerin for Angina Sales Forecast by Country (2027-2032)
- 7.2 North America Nitroglycerin for Angina Market Size by Country
- 7.2.1 North America Nitroglycerin for Angina Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Nitroglycerin for Angina Market Size by Country (2021-2026)
- 7.2.3 North America Nitroglycerin for Angina Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Nitroglycerin for Angina Sales by Country
- 8.1.1 Europe Nitroglycerin for Angina Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Nitroglycerin for Angina Sales by Country (2021-2026)
- 8.1.3 Europe Nitroglycerin for Angina Sales Forecast by Country (2027-2032)
- 8.2 Europe Nitroglycerin for Angina Market Size by Country
- 8.2.1 Europe Nitroglycerin for Angina Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Nitroglycerin for Angina Market Size by Country (2021-2026)
- 8.2.3 Europe Nitroglycerin for Angina Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Nitroglycerin for Angina Sales by Country
- 9.1.1 Asia-Pacific Nitroglycerin for Angina Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Nitroglycerin for Angina Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Nitroglycerin for Angina Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Nitroglycerin for Angina Market Size by Country
- 9.2.1 Asia-Pacific Nitroglycerin for Angina Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Nitroglycerin for Angina Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Nitroglycerin for Angina Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Nitroglycerin for Angina Sales by Country
- 10.1.1 South America Nitroglycerin for Angina Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Nitroglycerin for Angina Sales by Country (2021-2026)
- 10.1.3 South America Nitroglycerin for Angina Sales Forecast by Country (2027-2032)
- 10.2 South America Nitroglycerin for Angina Market Size by Country
- 10.2.1 South America Nitroglycerin for Angina Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Nitroglycerin for Angina Market Size by Country (2021-2026)
- 10.2.3 South America Nitroglycerin for Angina Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Nitroglycerin for Angina Sales by Country
- 11.1.1 Middle East and Africa Nitroglycerin for Angina Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Nitroglycerin for Angina Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Nitroglycerin for Angina Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Nitroglycerin for Angina Market Size by Country
- 11.2.1 Middle East and Africa Nitroglycerin for Angina Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Nitroglycerin for Angina Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Nitroglycerin for Angina Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Nitroglycerin for Angina Value Chain Analysis
- 12.1.1 Nitroglycerin for Angina Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Nitroglycerin for Angina Production Mode & Process
- 12.2 Nitroglycerin for Angina Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Nitroglycerin for Angina Distributors
- 12.2.3 Nitroglycerin for Angina Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst